Sarah T. Arron

9.0k total citations · 1 hit paper
131 papers, 4.4k citations indexed

About

Sarah T. Arron is a scholar working on Epidemiology, Oncology and Dermatology. According to data from OpenAlex, Sarah T. Arron has authored 131 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Epidemiology, 64 papers in Oncology and 49 papers in Dermatology. Recurrent topics in Sarah T. Arron's work include Nonmelanoma Skin Cancer Studies (68 papers), Cutaneous Melanoma Detection and Management (37 papers) and Cancer and Skin Lesions (28 papers). Sarah T. Arron is often cited by papers focused on Nonmelanoma Skin Cancer Studies (68 papers), Cutaneous Melanoma Detection and Management (37 papers) and Cancer and Skin Lesions (28 papers). Sarah T. Arron collaborates with scholars based in United States, United Kingdom and Spain. Sarah T. Arron's co-authors include Anne Lynn S. Chang, Simon Yoo, James Solomon, Michael R. Migden, Aleksandar Sekulić, Karl D. Lewis, Charles M. Rudin, Axel Hauschild, Philip Friedlander and Luc Dirix and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Sarah T. Arron

121 papers receiving 4.3k citations

Hit Papers

Efficacy and Safety of Vi... 2012 2026 2016 2021 2012 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma
    2012 1.0k citations Aleksandar Sekulić, Michael R. Migden et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah T. Arron United States 33 2.2k 1.7k 1.6k 1.6k 359 131 4.4k
María Teresa Fernández‐Figueras Spain 35 1.0k 0.5× 1.1k 0.7× 896 0.5× 1.4k 0.9× 830 2.3× 198 4.4k
Kishwer S. Nehal United States 35 2.0k 0.9× 1.6k 1.0× 550 0.3× 2.0k 1.3× 261 0.7× 154 4.0k
Charlotte M. Proby United Kingdom 50 4.2k 2.0× 2.5k 1.5× 1.5k 0.9× 2.8k 1.8× 843 2.3× 159 6.8k
Neil A. Fenske United States 40 1.8k 0.9× 1.9k 1.1× 840 0.5× 2.6k 1.7× 674 1.9× 163 5.7k
Matthias Volkenandt Germany 35 747 0.3× 991 0.6× 1.1k 0.7× 1.8k 1.1× 618 1.7× 141 3.8k
Sylvie Euvrard France 36 3.5k 1.6× 1.9k 1.2× 535 0.3× 3.1k 2.0× 511 1.4× 127 5.3k
Alan Storey United Kingdom 36 2.4k 1.1× 394 0.2× 1.6k 0.9× 1.8k 1.1× 613 1.7× 74 4.5k
David Weedon Australia 29 1.4k 0.6× 1.2k 0.7× 563 0.3× 1.0k 0.7× 278 0.8× 129 3.3k
Christopher K. Bichakjian United States 30 914 0.4× 561 0.3× 1.1k 0.7× 3.4k 2.2× 213 0.6× 61 4.7k
Robert S. Bart United States 38 1.9k 0.9× 2.2k 1.3× 1.2k 0.7× 3.6k 2.3× 438 1.2× 138 5.5k

Countries citing papers authored by Sarah T. Arron

Since Specialization
Citations

This map shows the geographic impact of Sarah T. Arron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah T. Arron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah T. Arron more than expected).

Fields of papers citing papers by Sarah T. Arron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah T. Arron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah T. Arron. The network helps show where Sarah T. Arron may publish in the future.

Co-authorship network of co-authors of Sarah T. Arron

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah T. Arron. A scholar is included among the top collaborators of Sarah T. Arron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah T. Arron. Sarah T. Arron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aasi, Sumaira Z., Murad Alam, Sarah T. Arron, et al.. (2024). The utility of artificial intelligence platforms for patient‐generated questions in Mohs micrographic surgery: a multi‐national, blinded expert panel evaluation. International Journal of Dermatology. 63(11). 1592–1598. 5 indexed citations
2.
3.
Arron, Sarah T., Javier Cañueto, Jennifer J. Siegel, et al.. (2024). Association of a 40-Gene Expression Profile With Risk of Metastatic Disease Progression of Cutaneous Squamous Cell Carcinoma and Specification of Benefit of Adjuvant Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 120(3). 760–771. 5 indexed citations
4.
Meyer, Jason M., E Lee, Kyungho Park, et al.. (2021). CERKL is upregulated in cutaneous squamous cell carcinoma and maintains cellular sphingolipids and resistance to oxidative stress*. British Journal of Dermatology. 185(1). 147–152. 5 indexed citations
5.
Knott, P. Daniel, Rahul Seth, Chase M. Heaton, et al.. (2021). Skin Color Match in Head and Neck Reconstructive Surgery. The Laryngoscope. 132(9). 1753–1759. 10 indexed citations
6.
Peebles, J. Klint, Matthew Mansh, Esther A. Kim, et al.. (2019). Trainee Exposure and Education for Minimally Invasive Gender-Affirming Procedures. Dermatologic Clinics. 38(2). 277–283. 4 indexed citations
7.
Johnson, Michael E., Jennifer M. Franks, Guoshuai Cai, et al.. (2019). Microbiome dysbiosis is associated with disease duration and increased inflammatory gene expression in systemic sclerosis skin. Arthritis Research & Therapy. 21(1). 49–49. 27 indexed citations
8.
Marks, Dustin H., Sarah T. Arron, & Matthew Mansh. (2019). Skin Cancer and Skin Cancer Risk Factors in Sexual and Gender Minorities. Dermatologic Clinics. 38(2). 209–218. 4 indexed citations
9.
Arron, Sarah T., et al.. (2019). Medications Associated with Increased Risk of Keratinocyte Carcinoma. Dermatologic Clinics. 37(3). 297–305. 3 indexed citations
10.
Levin, Ethan, et al.. (2018). Association of Postoperative Antibiotics With Surgical Site Infection in Mohs Micrographic Surgery. Dermatologic Surgery. 45(1). 52–57. 21 indexed citations
11.
Yanik, Elizabeth L., Ruth M. Pfeiffer, Martin A. Weinstock, et al.. (2017). Spectrum of Immune-Related Conditions Associated with Risk of Keratinocyte Cancers among Elderly Adults in the United States. Cancer Epidemiology Biomarkers & Prevention. 26(7). 998–1007. 21 indexed citations
12.
Stuart, Sarah, Chengshi Jin, Rupa Parvataneni, et al.. (2017). Tumor recurrence of keratinocyte carcinomas judged appropriate for Mohs micrographic surgery using Appropriate Use Criteria. Journal of the American Academy of Dermatology. 76(6). 1131–1138.e1. 10 indexed citations
13.
Lai, Kevin, Catherine Harwood, Karin J. Purdie, et al.. (2017). Genomic analysis of atypical fibroxanthoma. PLoS ONE. 12(11). e0188272–e0188272. 29 indexed citations
14.
Lowenstein, Stefan E., Giorgia L. Garrett, Amanda E. Toland, et al.. (2017). Risk prediction tools for keratinocyte carcinoma after solid organ transplantation: a review of the literature. British Journal of Dermatology. 177(5). 1202–1207. 17 indexed citations
15.
16.
Chang, Anne Lynn S., Karl D. Lewis, Sarah T. Arron, et al.. (2016). Safety and efficacy of vismodegib in patients aged ≥65 years with advanced basal cell carcinoma. Oncotarget. 7(46). 76118–76124. 17 indexed citations
17.
Raleigh, David R., et al.. (2015). Induction Hedgehog pathway inhibition followed by combined‐modality radiotherapy for basal cell carcinoma. British Journal of Dermatology. 173(2). 544–546. 21 indexed citations
18.
Sekulić, Aleksandar, Michael R. Migden, Karl D. Lewis, et al.. (2015). Pivotal ERIVANCE basal cell carcinoma (BCC) study: 12-month update of efficacy and safety of vismodegib in advanced BCC. Journal of the American Academy of Dermatology. 72(6). 1021–1026.e8. 154 indexed citations
19.
Sekulić, Aleksandar, Michael R. Migden, Anthony E. Oro, et al.. (2012). Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma. New England Journal of Medicine. 366(23). 2171–2179. 1011 indexed citations breakdown →
20.
Arron, Sarah T., Wilson Liao, & Toby Maurer. (2007). Scurvy: A presenting sign of psychosis. Journal of the American Academy of Dermatology. 57(2). S8–S10. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by María Teresa Fernández‐Figueras Breakdown of academic impact, for papers by Kishwer S. Nehal Breakdown of academic impact, for papers by Charlotte M. Proby Breakdown of academic impact, for papers by Neil A. Fenske Breakdown of academic impact, for papers by Matthias Volkenandt Breakdown of academic impact, for papers by Sylvie Euvrard Breakdown of academic impact, for papers by Alan Storey Breakdown of academic impact, for papers by David Weedon Breakdown of academic impact, for papers by Christopher K. Bichakjian Breakdown of academic impact, for papers by Robert S. Bart
Rankless by CCL
2026